Xxera/openscience/retractions

Record #36327

Targeting PI3KC2β impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumours

Journal

Anticancer Research

Publisher

International Institute of Anticancer Research

Original paper date

Jul 25, 2012

Original DOI

Country

🇫🇷 France · 🇯🇵 Japan · 🇨🇭 Switzerland · 🇬🇧 United Kingdom

Institution

Division of Clinical Chemistry and Biochemistry, University Children’s Hospital Zurich, Zurich, Switzerland · Department of Oncology, University Children’s Hospital Zurich, Zurich, Switzerland · PIramed, Slough, Berkshire, UK · Drug Discovery Research, Astellas Pharma Inc., Tsukuba, Ibaraki, Japan · INSERM U509, Paris, France · Department of Clinical Research, University of Bern, Bern, Switzerland · Department of Neurosurgery, University Hospital Zurich, Zurich, Switzerland · Service and Central Laboratory of Hematology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland · Ludwig Institute for Cancer Research, Proteomics Unit, London, U.K

Open access

No

Article type

Research Article

Broad categories

(BLS) Biology - Cancer (BLS) Biology - Cellular (BLS) Neuroscience

Citation lifecycle

How this paper is being cited

Pre-retraction

28

Same day

0

Post-retraction

4

% post-retraction

12.5%

~3.1 citations/yr before retraction · ~0.8 citations/yr after

— citing papers

Who is still citing this work

Loading…